| Literature DB >> 30116259 |
Atakilt Abebe1, Minaleshewa Atlabachew1, Misganaw Liyew2, Elsabet Ferede2.
Abstract
New organic salts were synthesized by quaternizing 1,10-phenanthroline using 1-bromotetradecane. The first step yielded an organic salt of formula [C26H37N2]Br. Anion exchange reaction using Li[(CF3SO2)2N] resulted in a more stable salt of formula [C26H37N2][(CF3SO2)2N]. The organic salts were investigated by spectrometry (1H, 13C, 19F NMR, X-ray photoelectron spectroscopy (XPS), UV-Vis, and matrix-assisted laser desorption/ionization mass spectroscopy (MALDI MS), CHNSBr elemental analysis, and thermal analysis (TGA and DSC). The thermal characterization showed the melting and decomposition points of [C26H37N2][(CF3SO2)2N] to be 48°C and 290°C, respectively, which indicates it is an ionic liquid with large liquidus range. The biological activities of the salts were investigated against two Gram-positive (Staphylococcus aureus and Streptococcus pyogenes) and two Gram-negative (Escherichia coli and Klebsiella pneumoniae) bacteria, and they are found to be active against all of them. They were compared with [Cu(1,10-phenanthroline)2Cl]Cl. They are found more active against the Gram-negative bacteria. The salts demonstrated minimum inhibitory concentration as low as 50 µg/L. These results suggest the synthesized salts can be considered as a better alternative to certain transition metal complex drugs. This minimizes the concern of introducing metal ions into the organism.Entities:
Year: 2018 PMID: 30116259 PMCID: PMC6079542 DOI: 10.1155/2018/8097483
Source DB: PubMed Journal: Bioinorg Chem Appl Impact factor: 7.778
Scheme 1Synthesis path of the salts.
CHNBrS elemental analysis measurements.
| Compound | Elemental estimation | ||||
|---|---|---|---|---|---|
| Calculated (found) (%) | |||||
| H | C | N | Br | S | |
| [C26H37N2]Br | 8.10 (7.98) | 68.27 (68.04) | 6.13 (6.00) | 17.51 (17.28) | — |
| [C26H37 N2][(CF3SO2)2N] | 5.67 (5.64) | 51.14 (51.01) | 6.39 (6.28) | — | 9.74 (9.59) |
Figure 1X-ray photoelectron spectrum recorded for (a) survey, (b) wide scan for C1s, (c) wide scan for N1s, (d) wide scan for F1s, (e) wide scan for O1s, and (f) wide scan for S2p of [C26H37N2][(CF3SO2)2N].
Figure 2(a) MALDI MS+ and (b) MALDI MS for [C26H37N2][(CF3SO2)2N].
Figure 3UV-Vis spectra of 1,10-phenanthroline and [C26H37N2][(CF3SO2)2N].
Starting point and onset temperatures with the weight loss curves and melting and crystallization temperatures of the salts.
| Compound | Temperature (°C) | ||||
|---|---|---|---|---|---|
| Start | Onset | Glass transition | Crystallization | Melting | |
| [C26H37N2]Br | 129.72 | 157.41 | — | — | — |
| [C26H37N2][(CF3SO2)2N] | 244.41 | 290.31 | −0.60 | −11.28 | 48.77 |
Figure 4The inhibition observed by the actions of the salts.
Antibacterial studies of the investigated compounds (inhibition zones).
| Compound | Inhibition zone (mm) | |||
|---|---|---|---|---|
| Gram-negative bacteria | Gram-positive bacteria | |||
|
|
|
|
| |
| [C26H37 N2]Br | 19.75 | 19.75 | 16.50 | 25.00 |
| [C26H37 N2][(CF3SO2)2N] | 20.25 | 20.25 | 23.50 | 20.25 |
| Gentamicin | 31.25 | 25.00 | 26.50 | 28.25 |
| [Cu(Phen)2Cl]Cl | 15.00 | 17.25 | 29.75 | 29.50 |
| 1,10-Phenanthroline | 36.00 | 18.75 | 36.00 | 31.25 |
MIC assays of the salts against four bacterial pathogens.
| Compound | Minimum concentration of microorganism growth ( | |||
|---|---|---|---|---|
| Gram-negative bacteria | Gram-positive bacteria | |||
|
|
|
|
| |
| [C26H37 N2]Br | 50 | 50 | 50 | 50 |
| [C26H37 N2][(CF3SO2)2N] | 50 | 75 | 75 | 75 |
| [Cu(Phen)2Cl]Cl | 100 | 125 | 75 | 75 |